Nadim Ahmed was appointed CEO and Jeffrey Jones was appointed CMO of Cullinan Therapeutics, Inc. on August 22, 2025.
2 reports, 1 independent
Updated Aug 22
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Nadim Ahmed was appointed CEO and Jeffrey Jones was appointed CMO of Cullinan Therapeutics, Inc. on August 22, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Nadim Ahmed and Jeffrey Jones took on leadership roles at Cullinan Therapeutics.1 source
Andrew Allen joins Cullinan Therapeutics' Board of Directors.1 source
Keep exploring
The entities involved
-
Nadim Ahmed
Bangladeshi cricketer
Nothing else this week.
-
Jeffrey Jones
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireCullinan Therapeutics to Participate in Upcoming Investor Conferences CAMBRIDGE, Mass., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical c
- GlobeNewswireCullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results CLN-978 program now actively enrolling across Phase 1 studies in systemic lupus erythematosus (SLE),